Dawicki-McKenna, Jennine M. http://orcid.org/0000-0002-1293-640X
Felix, Alex J. http://orcid.org/0000-0002-7145-7169
Waxman, Elisa A. http://orcid.org/0000-0003-4562-7969
Cheng, Congsheng
Amado, Defne A. http://orcid.org/0000-0001-6202-3900
Ranum, Paul T.
Bogush, Alexey
Dungan, Lea V.
Maguire, Jean Ann
Gagne, Alyssa L. http://orcid.org/0000-0002-5636-4618
Heller, Elizabeth A. http://orcid.org/0000-0002-2984-8705
French, Deborah L.
Davidson, Beverly L.
Prosser, Benjamin L. http://orcid.org/0000-0003-3696-9131
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke (NS118280)
Article History
Received: 12 July 2022
Accepted: 22 April 2023
First Online: 6 May 2023
Competing interests
: Provisional patent 22-9943, “Compositions for treating SYNGAP-1 neurodevelopmental disorders”, which covers certain antisense oligonucleotides described herein, has been filed on behalf of J.M.D-M., A.J.F., B.L.D., B.L.P. and assigned to the University of Pennsylvania and Children’s Hospital of Philadelphia. The authors declare no additional competing interests.